Chitosan and β-cyclodextrin microspheres as pulmonary sustained delivery systems

Weifen Zhang , Xiguang Chen , Piwu Li , Qiangzhi He , Huiyun Zhou , Dongsu Cha

Journal of Wuhan University of Technology Materials Science Edition ›› 2008, Vol. 23 ›› Issue (4) : 541 -546.

PDF
Journal of Wuhan University of Technology Materials Science Edition ›› 2008, Vol. 23 ›› Issue (4) : 541 -546. DOI: 10.1007/s11595-006-4541-9
Article

Chitosan and β-cyclodextrin microspheres as pulmonary sustained delivery systems

Author information +
History +
PDF

Abstract

Chitosan and β-cyclodextrin were used to prepare microspheres with theophylline for pulmonary delivery by spray drying method. The characteristics, mucociliotoxicity, permeation rate and drug release were studied. The drug entrapments of microspheres I, II and III were from 35.70% to 21.09% and 13.33%, while yields and encapsulation efficiencies were higher than 45% and about 90% respectively. The microspheres possessed low tap densities (0.34–0.48 g/cm3), appropriate diameters (3.35–3.94 μm) and theoretical aerodynamics diameters (2.20–3.04 μm). SEM images showed the microspheres were spherical with smooth or wrinkled surface surfaces. FT-IR demonstrated theophylline had formed hydrogen bonds with chitosan and β-cyclodextrin. The microspheres could effectively reduce the ciliotoxicity and easy to penetrate the memberine. The in vitro release of the microspheres was related to the ratio of drug/polymer and microspheres II had a prolong release, providing the release of 72.00% in 12 h. The results suggestes that chitosan/β-cyclodextrin microspheres II are a promising carrier as sustained release for pulmonary delivery.

Keywords

theophylline / chitosan / spray-drying / microspheres / pulmonary delivery

Cite this article

Download citation ▾
Weifen Zhang, Xiguang Chen, Piwu Li, Qiangzhi He, Huiyun Zhou, Dongsu Cha. Chitosan and β-cyclodextrin microspheres as pulmonary sustained delivery systems. Journal of Wuhan University of Technology Materials Science Edition, 2008, 23(4): 541-546 DOI:10.1007/s11595-006-4541-9

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Zeng X. M., Martin G. P., Marriott C. The Controlled Delivery of Drugs to the Lung[J]. Int. J. Pharm., 1995, 124: 149-164.

[2]

Smith S. J., Bernstein J. A. Therapeutic Uses of Lung Aerosols. In Inhalation Aerosols: Physical and Biological Basis for Therapy[M], 1996. New York: Marcel Dekker, Inc.. 233-269.

[3]

Behl C. R., Pimplaskar H. K., Sileno A. P., . Effect of Physiochemical Properties and other Factors on Systemic Nasal Drug Delivery[J]. Adv. Drug. Deliver. Rev., 1998, 29: 89-116.

[4]

Kawashima Y., Yamamoto H., Takeuchi H., . Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin[J]. Pharm. Dev. Technol., 2000, 5: 77-85.

[5]

Zhou H. Y., Chen X. G., Liu C. S., . Chitosan/Cellulose Acetate Microspheres Preparation and Ranitidine Release in Vitro[J]. Pharm. Dev. Technol., 2005, 10: 219-225.

[6]

Okamoto H., Nishida S., Todo H., . Pulmonary Gene Delivery by Chitosan-p DNA Complex Powder Prepared by a Supercritical Carbon Dioxide Process[J]. J. Pharm. Sci., 2003, 92: 371-380.

[7]

Davis S. S. Delivery of Peptide and Non-peptide Drugs through the Respiratory Tract[J]. Pharm. Sci. Technol. Today, 1999, 2: 450-456.

[8]

Yamamoto H., Kuno Y., Sugimoto S., . Surface-modified PLGA Nanosphere with Chitosan Improved Pulmonary Delivery of Calcitonin by Mucoadhesion and Opening of the Intercellular Tight Junctions[J]. J. Control. Release, 2005, 102: 373-381.

[9]

Asada M., Takahashi H., Okamoto H., . Theophylline Particle Design Using Chitosan by the Spray Drying[J]. Int. J. Pharm., 2004, 270: 167-174.

[10]

Huang Y. C., Yeh M. K., Chiang C. H. Formulation Factors in Preparing BTM-chitosan Microspheres by Spray Drying Method[J]. Int. J. Pharm., 2002, 242: 239-242.

[11]

Maestrelli F., Zerrouk N., Chemtob C., . Influence of Chitosan and Its Glutamate and Hydrochloride Salts on Naproxen Dissolution Rate and Permeation Across Caco-2 Cells[J]. Int. J. Pharm., 2004, 271: 257-267.

[12]

Kinnarinen T., Jarho P., Järvinen K., . Pullmonary Deposition of a Budesonide/γ-cyclodextrin Complex in vitro[J]. J. Control. Release, 2003, 90: 197-205.

[13]

Fiegel J., Fu J., Hanes J. Poly (ether-anhydride) Dry Powder Aerosols for Sustained Drug Delivery in the Lungs[J]. J. Control. Release, 2004, 96: 411-423.

[14]

Zhao L., Jiang B., Wang M. Y., . Study on Ciliotoxicity and Mucoadhesion of Chitosan Microspheres[J]. Chin. Hosp. Pharm. J., 2005, 25: 697-699.

[15]

Jin F., Xie B. Y., Shi L. X. Studies on Disodium Cromoglycate Carrier-free Powder Inhalation: II in Vitro Evaluation of Powders for Inhalation[J]. Chin. J. Pharm., 1998, 29: 19-22.

[16]

Bosquillon C., Lombry C., Préat V., . Influence of Formulation Excipients and Physical Characteristics of Inhalation Dry Powders on Their Aerosolization Performance[J]. J. Control. Release, 2001, 70: 329-339.

[17]

He P., Davis S. S., Illum L. Chitosan Microspheres Prepared by Spray Drying[J]. Int. J. Pharm., 1999, 187: 53-65.

[18]

Chidavaenzi O. C., Buckton G., Koosha F., . The Use of Thermal Techniques to Assess the Impact of Feed Concentration on the Amorphous Content and Polymorphic Forms Present in Spray Dried Lactose[J]. Int. J. Pharm., 1997, 159: 67-74.

AI Summary AI Mindmap
PDF

144

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/